跳至主要内容
临床试验/KCT0007801
KCT0007801已完成未知

Finding 50% effective dose of remimazolam for facilitating I-gel insertion with remifentanil target-controlled infusion

Ajou University Hospital0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

The remimazolam bolus dose for successful I-gel insertion in 50% of adult patients with Ce 3.0 ng/mL of remifentanil and without NMBAs was 0.280 ± 0.048 mg/kg. From the isotonic regression analysis, ED50 and ED95 were 0.244 (83% CI 0.213–0.313) mg/kg and 0.444 (95% CI 0.436–0.448) mg/kg, respectively.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 65(Year)(—)
性别
All

入选标准

  • Adult patients aged 19-65 years with ASA score 1 or 2 scheduled for general anesthesia and eligible for I-gel use

排除标准

  • BMI > 30 kg/m2
  • Patient refusal
  • Anticipated difficult airway
  • Anticipated difficult mask ventilation
  • COPD, astham, pneumonia, active URI
  • Risk of aspiration
  • Patients unable to response on verbal command
  • History of allergies to benzodiazepines
  • History of allergies to opioids
  • History of substance abuse/addiction
  • Pregnant or breastfeeding patients

研究者

发起方
Ajou University Hospital

相似试验